Toxicity Reduced With MRI-Guided Radiotherapy for Prostate Cancer
Medically reviewed by Drugs.com.
By Elana Gotkine HealthDay Reporter
MONDAY, July 24, 2023 -- For patients with prostate cancer, magnetic resonance‐guided daily adaptive stereotactic body radiotherapy (MRg-A-SBRT) is associated with reduced toxicity compared with computed tomography‐guided nonadaptive prostate SBRT (CT-SBRT), according to a systematic review and meta‐analysis published online July 24 in Cancer.
Jonathan E. Leeman, M.D., from the Dana‐Farber Cancer Institute/Brigham and Women's Hospital in Boston, and colleagues conducted a meta-analysis to compare acute toxicity rates associated with MRg‐A‐SBRT and CT‐SBRT for prostate cancer. A total of 29 prospective studies, with 2,547 patients, met the inclusion criteria.
The researchers found that the pooled estimates for acute grade 2 or higher (G2+) genitourinary and gastrointestinal toxicity were 16 and 4 percent, respectively, for MRg-A-SBRT, compared with 28 and 9 percent, respectively, for CT-SBRT. The odds ratios for acute G2+ genitourinary and gastrointestinal toxicities comparing MRg-A-SBRT and CT-SBRT were 0.56 and 0.40, respectively, on meta-regression.
"Because there are multiple technical differences between these approaches, further prospective investigation is needed to pinpoint the specific underlying causes, and in particular the role of daily adaptive planning," the authors write. "Whether late toxicity and cancer control rates differ with the use of MRg‐A‐SBRT compared to CT‐SBRT will require longer follow‐up to determine."
Several authors disclosed ties to the biopharmaceutical industry.
Abstract/Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted July 2023
Read this next
BMI Cutoff of 30 for Obesity May Be Too High for Middle-Aged, Older Adults
FRIDAY, May 31, 2024 -- The optimal body mass index (BMI) cutoff point appears to be 27 kg/m2 for detecting obesity in middle-aged and older adults, according to a study presented...
Emergency Inguinal Hernia Surgery Rates Increased With Lower Country Income
FRIDAY, May 31, 2024 -- For patients undergoing inguinal hernia surgery, emergency surgery rates increase from high- to low-income countries, according to a study published online...
Maternal Serum Alpha-Fetoprotein Levels Higher in Black Than White Women
FRIDAY, May 31, 2024 -- Maternal serum alpha-fetoprotein (AFP) levels are higher in Black than White pregnant women, supporting the use of accounting for these differences in...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.